Read + Share
Dai C, Huang YH, Jiang M. Comparative Risk of Serious Infection With Vedolizumab vs Anti-Tumor Necrosis
Factors in Inflammatory Bowel Disease. Am J Gastroenterol 2024 Aug 19. doi: 10.14309/ajg.0000000000002995.
PMID: 39158155
|
 |
|
Dai C, Huang YH, Jiang M. Comparative Risk of Serious Infection With Vedolizumab vs Anti-Tumor Necrosis
Factors in Inflammatory Bowel Disease. Am J Gastroenterol 2024 Aug 19. doi: 10.14309/ajg.0000000000002995.
PMID: 39158155
|
|
|
|